Approximately 93,481 bottles of RILEXINE (cephalexin) Chewable Tablets for dogs are being voluntarily recalled due to multiple labeling defects and potential packaging issues. Affected bottles may have missing or double labels, or may be missing critical lot and expiration date information. Additionally, some bottles within these lots may have loose or incompletely sealed foil liners under the cap, which could compromise the integrity of the medication.
Missing or illegible labels can lead to incorrect dosing or the use of expired medication, while compromised foil seals may allow moisture or contaminants to enter the bottle, potentially reducing the drug's effectiveness or safety for the animal.
Drug recall return policy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response